Mitsuyoshi Azuma

Director/Board Member at Senju Pharmaceutical Co., Ltd.

Health Technology

Profile

Mitsuyoshi Azuma is currently a Director & Managing Executive Officer at Senju Pharmaceutical Co., Ltd.
and a Director at Neuroptika, Inc. He was formerly a Director at SemaThera, Inc.

Mitsuyoshi Azuma active positions

Companies	Position	Start
Senju Pharmaceutical Co., Ltd. Senju Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Senju Pharmaceutical Co., Ltd. manufactures and distributes pharmaceuticals. It produces drugs for inflammation, allergy, glaucoma, cataract, and infection. The company was founded on April 9, 1947 and is headquartered in Osaka, Japan.	Director/Board Member	-
Neuroptika, Inc. Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA.	Director/Board Member	-

All active positions of Mitsuyoshi Azuma

Former positions of Mitsuyoshi Azuma

Companies	Position	End
SemaThera, Inc. SemaThera, Inc. BiotechnologyHealth Technology SemaThera, Inc. engages in research and development in biotechnology. It develops novel inhibitors against semaphorin 3A (SEMA 3A) for prevention and reversal of diabetic macular edema (DME). The company is headquartered in Montreal, Canada.	Director/Board Member	-

See the detail of Mitsuyoshi Azuma's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mitsuyoshi Azuma's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Senju Pharmaceutical Co., Ltd. Senju Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Senju Pharmaceutical Co., Ltd. manufactures and distributes pharmaceuticals. It produces drugs for inflammation, allergy, glaucoma, cataract, and infection. The company was founded on April 9, 1947 and is headquartered in Osaka, Japan.	Health Technology
Neuroptika, Inc. Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA.	Health Technology
SemaThera, Inc. SemaThera, Inc. BiotechnologyHealth Technology SemaThera, Inc. engages in research and development in biotechnology. It develops novel inhibitors against semaphorin 3A (SEMA 3A) for prevention and reversal of diabetic macular edema (DME). The company is headquartered in Montreal, Canada.	Health Technology

See company connections

Stock Market
Insiders
Mitsuyoshi Azuma